---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-099755"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2025-10-17T23:59:59+00:00"
generated_at: "2026-05-17T03:24:47.361564+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# BiomX shareholders approve reverse stock split authorization and elect Class II directors

## Summary
- Elected Susan Blum, Dr. Jesse Goodman, and Gregory Merril as Class II directors until 2028.
- Approved board authority to reverse split common stock at a ratio between 1-for-5 and 1-for-20 (13.6M votes for, 383.7K against).
- Ratified Kesselman & Kesselman (PwC member) as independent auditor for fiscal 2025 with 14.05M votes for.
- Adjournment proposal not called due to sufficient votes on other proposals.
- All three proposals passed; broker non-votes were zero on director elections.

## SEC filing metadata
- accession: 0001213900-25-099755
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2025-10-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390025099755/0001213900-25-099755-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390025099755/ea0261608-8k_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-099755
- JSON: https://secwatch.observer/filing/0001213900-25-099755.json
- Plain text: https://secwatch.observer/filing/0001213900-25-099755.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.